Table 2 Total self-efficacy score by socio-demographic and clinical variables
Variable | Frequency % N(300) | Median (Q1–Q3) | Mean ± SD | Mean rank | P-value |
|---|---|---|---|---|---|
Age category (years) | < 0.001 b | ||||
< 30 | 31 (10.3) | 47.00(41.00–50.00) | 44.32 ± 9.09 | 205.84 | |
30–60 | 163 (54.3) | 41.00(35.00–46.00) | 39.36 ± 9.38 | 158.72 | |
> 60 | 106 (35.3) | 35.00(30.00–42.00) | 35.23 ± 9.80 | 121.68 | |
Gender | 0.311 a | ||||
Male | 115 (38.3) | 40.00(33.00–47.00) | 39.09 ± 10.46 | 156.93 | |
Female | 185 (61.7) | 39.00(32.00–45.00) | 37.99 ± 9.52 | 146.50 | |
BMIa | 0.146b | ||||
Normal | 65 (21.7) | 41.00(39.00–49.00) | 40.13 ± 9.51 | 163.11 | |
Overweight | 136 (45.3) | 39.00(34.00–45.00) | 38.35 ± 9.05 | 147.75 | |
Obese | 93 (31.0) | 38.00(31.00–44.00) | 37.09 ± 9.97 | 136.19 | |
Education | < 0.001 b | ||||
Illiterate | 20 (6.7) | 29.50(21.75–41.50) | 30.70 ± 11.37 | 90.18 | |
Elementary | 43 (14.3) | 35.00(28.00–41.00) | 36.14 ± 9.42 | 123.37 | |
Primary | 52 (17.3) | 37.00(31.00–42.00) | 36.45 ± 9.77 | 130.83 | |
Secondary | 54 (18.0) | 41.00(36.75–48.00) | 40.65 ± 9.91 | 167.40 | |
University | 124 (41.3) | 41.50(34.00–47.00) | 39.85 ± 9.18 | 159.59 | |
Income (month) | 0.432b | ||||
Less than 2000 NIS | 23 (7.7) | 41.00(31.00–45.00) | 37.61 ± 11.70 | 145.93 | |
2000–5000 NIS | 160(53.3) | 39.00(31.00–45.00) | 38.00 ± 9.66 | 140.54 | |
More than 5000 NIS | 108(36.0) | 41.00 (35.00–46.00) | 39.31 ± 10.07 | 154.10 | |
locality | 0.675 b | ||||
Camp | 36 (12.0) | 38.50(31.25–45.75) | 37.53 ± 9.46 | 138.42 | |
Rural | 85(28.3) | 39.00(31.00–44.00) | 38.11 ± 9.51 | 143.67 | |
Urban | 172(57.3) | 39.00(34.00–46.75) | 38.76 ± 10.18 | 150.44 | |
Marital status | 0.103a | ||||
Married | 229(76.3) | 12.00(11.00–14.00) | 39.00 ± 9.52 | 152.59 | |
Unmarried (single, divorced, widowed) | 67(22.3) | 11.00(10.00–13.00) | 36.25 ± 10.97 | 133.50 | |
Employment status | 0.049 a | ||||
Employed | 194(64.7) | 42.00(34.00–48.00) | 40.04 ± 10.26 | 161.07 | |
Unemployed | 100(33.3) | 38.00(32.00–44.25) | 37.82 ± 9.24 | 140.51 | |
Chronic co-morbid disease | 0.034 b | ||||
No co-morbid disease | 42 (14.0) | 42.00(35.00–47.00) | 40.29 ± 8.89 | 166.74 | |
One disease | 44(14.7) | 42.00(34.00–49.00) | 40.30 ± 10.56 | 164.71 | |
Two diseases | 63(21.0) | 40.00 (33.00–47.00) | 39.43 ± 8.89 | 156.02 | |
Three diseases or more | 146(48.7) | 37.00(30.75–44.00) | 36.76 ± 10.32 | 133.22 | |
Indications for anticoagulant | 0.001 b | ||||
Atrial fibrillation | 63 (21.0) | 36.00 (27.00–41.00) | 34.02 ± 10.51 | 115.01 | |
Deep vein thrombosis or Pulmonary embolism | 29 (9.7) | 43.00 (34.51–49.50) | 42.76 ± 7.79 | 187.07 | |
Prophylaxisc | 72 (24.0) | 39.50 (35.00–46.75) | 38.63 ± 8.83 | 152.99 | |
Other indications | 136 (45.3) | 41.00 (33.00–47.00) | 39.40 ± 9.90 | 157.82 | |
Chronic medications | 0.029 a | ||||
≤ 4 | 176(58.7) | 41.00(33.25–47.00) | 39.32 ± 9.95 | 159.76 | |
> 4 | 124(41.3) | 37.00(32.00–44.00) | 37.11 ± 9.68 | 137.49 | |
Anticoagulant drug | 0.002 b | ||||
UHF | 87(29) | 40.00(35.00–46.00) | 39.02 ± 8.45 | 154.05 | |
Vit-K dependent | 134(44.7) | 35.00(30.25–42.00) | 35.18 ± 9.74 | 119.38 | |
NOACs | 75(25) | 41.00(33.75–47.00) | 39.00 ± 8.20 | 161.20 | |